Countries China
WuXi Biologics Received First GMP manufacturing authorization outside of China
First GMP manufacturing authorization outside of China, validating WuXi Biologics' world-class quality system Only 12 months from facility qualific...
July 26, 2021 | News
I-Mab Expands Next Generation Novel Oncology Therapeutics
I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel bio...
July 10, 2021 | News
Univercells Tech and VectorBuilder announce partnership for optimized custom viral vector production
Agreement to encompass co-development and optimization of protocols for intensified and continuous viral vector production for cell and gene therapies and ...
July 07, 2021 | News
Arctic Vision to develop innovative therapies for pan-ocular diseases
Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today...
July 05, 2021 | News
RauCon Signs Second Partnership Agreement for Chinese Pharma Market
According to the agreements, RauCon will promote both companies’ service offers while Ling med and GBI will promote RauCon’s Marketplaces for P...
July 02, 2021 | News
I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio
First patient dosed in U.S. phase 1 clinical trial of TJ-CD4B/ABL111 in patients with advanced or metastatic solid tumors China sites to join the d...
July 02, 2021 | News
OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies
OnCusp successfully closed its seed round financing of $25 million on April 1, 2021, led by Sequoia Capital and Biotrack Capital, followed b...
July 01, 2021 | News
Clover Announces Advance Purchase Agreement with Gavi
Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address ...
June 30, 2021 | News
Innovent Announces An Agreement with Synaffix
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medi...
June 29, 2021 | News
The Third Asia Pacific Psychiatry Symposium Takes Place
The global COVID-19 pandemic poses a serious threat to physical health and has wide-ranging implications for mental health worldwide. At the third Asia Pac...
June 29, 2021 | News
Peijia Medical leads China into the "Retrievable Era" using TAVR products
The TaurusElite® Transcatheter Aortic Valve Replacement System (hereinafter referred to as "TaurusElite®") developed by Peijia Medical (9996.H...
June 28, 2021 | News
China's Public Health System Primed for Digital Innovation
China's Public Health System Primed for Digital Innovation Online/Offline Service Delivery 'Huge Growth Opportunity', says Ping An Co-CEO Ms. Tan ...
June 26, 2021 | News
Zuellig Pharma to advance Cyber-intelligence Capabilities
Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture CYFIRMA, a threat discovery and cyb...
June 25, 2021 | News
China's first CAR-T Cell Therapy (FKC876) approved
The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy in China Individualized living-cell-based medicine: genetica...
June 24, 2021 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
